ConductScience.org, home

Paper406347

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Halstead SB and 1 other. J Exp Med, 1977. Cited by 687 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. Papers, record 406347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/406347

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.
PubMed
Journal
J Exp Med
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
687
iCite
Relative citation ratio, by iCite
13.5
iCite
Revised in PubMed
2019-05-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Halstead SBS B
2O'Rourke EJE J

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ViralMajor topic
Dengue VirusMajor topic
PhagocytesMajor topic
Animals
Binding Sites, Antibody
Haplorhini
Hemagglutination Inhibition Tests
Heparin
Humans
Immunity, Cellular
Immunoglobulin G
Immunoglobulin M
Leukocytes
Macaca mulatta
Neutralization Tests
Peptide Hydrolases
Virus Replication

Source PubMed

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117,319,077Immunological enhancement of dengue virus replication.Nat New Biol1973https://conductscience.org/library/papers/17319077PubMed
214,427,334Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.Arch Biochem Biophys1960https://conductscience.org/library/papers/14427334PubMed
6195,000Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection.J Exp Med1977https://conductscience.org/library/papers/195000PubMed
7404,559Antibody-enhanced dengue virus infection in primate leukocytes.Nature1977https://conductscience.org/library/papers/404559PubMed
81,008,131Shock syndrome in primary dengue infections.Am J Trop Med Hyg1976https://conductscience.org/library/papers/1008131PubMed
9992,710Effects of activated complement components on enzyme secretion by macrophages.Immunology1976https://conductscience.org/library/papers/992710PubMed
104,183,812A simple micro-culture method for the study of group B arboviruses.Bull World Health Organ1969https://conductscience.org/library/papers/4183812PubMed
115,419,208Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.Yale J Biol Med1970https://conductscience.org/library/papers/5419208PubMed
125,419,206Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.Yale J Biol Med1970https://conductscience.org/library/papers/5419206PubMed
135,419,205Observations related to pathogenesis of dengue hemorrhagic fever. 3. Virologic studies of fatal disease.Yale J Biol Med1970https://conductscience.org/library/papers/5419205PubMed
145,464,392Observations related to the pathogenesis of dengue hemorrhagic fever. II. Antigenic and biologic properties of dengue viruses and their association with disease response in the host.Yale J Biol Med1970https://conductscience.org/library/papers/5464392PubMed
155,795,449Recurrence of epidemic dengue hemorrhagic fever in an insular setting.Am J Trop Med Hyg1969https://conductscience.org/library/papers/5795449PubMed
164,164,665Production and characterization of arbovirus antibody in mouse ascitic fluid.Am J Trop Med Hyg1967https://conductscience.org/library/papers/4164665PubMed
174,191,812
The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.
Immunology1970https://conductscience.org/library/papers/4191812PubMed
184,390,977Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area.Am J Trop Med Hyg1969https://conductscience.org/library/papers/4390977PubMed
194,319,925Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells.Science1970https://conductscience.org/library/papers/4319925PubMed
204,623,314Leukotactic factors elaborated by virus-infected tissues.J Exp Med1972https://conductscience.org/library/papers/4623314PubMed
214,198,025Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections.J Infect Dis1973https://conductscience.org/library/papers/4198025PubMed
224,198,024Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection.J Infect Dis1973https://conductscience.org/library/papers/4198024PubMed
23240,884Interaction of C3b, B, and D in the alternative pathway of complement activation.J Immunol1975https://conductscience.org/library/papers/240884PubMed

See all 31 references

Cited by377

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 687 citations.

PMIDTitleJournalYearIn PapersSource
42,843,521Monocyte-associated C1q upregulation and complement activation contribute to vascular endothelial and multi-organ injury in severe dengue.Virol Sin2026https://conductscience.org/library/papers/42843521PubMed
42,474,186Molecular and biophysical requirements for B cell receptor-dependent enhancement of dengue virus infection.J Virol2026https://conductscience.org/library/papers/42474186PubMed
42,069,749Lipid nanoparticle-encapsulated DNA vaccine prevented lung consolidation following heterologous influenza A virus challenge in pigs.NPJ Vaccines2026https://conductscience.org/library/papers/42069749PubMed
41,959,375CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design.bioRxiv2026https://conductscience.org/library/papers/41959375PubMed
41,925,943Purinergic signaling in dengue infection: modulation of P2 receptors as a potential therapeutic strategy.Purinergic Signal2026https://conductscience.org/library/papers/41925943PubMed
41,889,646Advances in anti-dengue virus properties of Traditional Chinese Medicines.Front Microbiol2026https://conductscience.org/library/papers/41889646PubMed
41,857,105Anti-DENV IgE correlates with dengue severity and triggers FcεRI-dependent basophil activation inhibited by Omalizumab.Sci Rep2026https://conductscience.org/library/papers/41857105PubMed
41,729,079SARS-CoV-2 antibody-dependent enhancement of infection depends on antibody binding to both ACE2 and Fc receptors.JCI Insight2026https://conductscience.org/library/papers/41729079PubMed
41,727,479Dengue-SARS-CoV-2 interactions: immune crosstalk, variant emergence, and clinical outcomes.Front Immunol2026https://conductscience.org/library/papers/41727479PubMed
41,650,176B Cell Receptor's function in virus entry: Anti-SARS-CoV-2 B cell receptors can mediate viral entry in an ACE2-independent mechanism.PLoS Pathog2026https://conductscience.org/library/papers/41650176PubMed
41,542,475Molecular and biophysical requirements for B cell receptor dependent enhancement of dengue virus infection.bioRxiv2026https://conductscience.org/library/papers/41542475PubMed
41,097,095Viral Metagenomic Next-Generation Sequencing for One Health Discovery and Surveillance of (Re)Emerging Viruses: A Deep Review.Int J Mol Sci2025https://conductscience.org/library/papers/41097095PubMed
40,910,631Dengue and severe dengue.Clin Microbiol Rev2025https://conductscience.org/library/papers/40910631PubMed
40,587,809Genetic ancestry shapes dengue virus infection in human skin explants.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40587809PubMed
40,563,017Efficacy, public health impact and optimal use of the Takeda dengue vaccine.Nat Med2025https://conductscience.org/library/papers/40563017PubMed
40,360,744Dengue Dilemma: Navigating Cross-Reactivity and Immune Challenges.Curr Top Microbiol Immunol2026https://conductscience.org/library/papers/40360744PubMed
40,336,275Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition.J Infect Dis2025https://conductscience.org/library/papers/40336275PubMed
40,168,990Immunological drivers of zoonotic virus emergence, evolution, and endemicity.Immunity2025https://conductscience.org/library/papers/40168990PubMed
40,044,132Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates.J Microbiol2025https://conductscience.org/library/papers/40044132PubMed
39,990,674Antibody-dependent enhancement of coronaviruses.Int J Biol Sci2025https://conductscience.org/library/papers/39990674PubMed

See all 377 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/406347

GET https://conductscience.org/api/papers/v1/406347/references?page=2